SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-19-002023
Filing Date
2019-03-25
Accepted
2019-03-25 16:03:30
Documents
1
Period of Report
2019-03-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4/A  
1 PRIMARY DOCUMENT primarydocument.xml 4/A 3525
  Complete submission text file 0001562180-19-002023.txt   4965
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Issuer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451
Business Address
Meyers Michael L. (Reporting) CIK: 0001664204 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37708 | Film No.: 19702698